| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |